Prestige Consumer Healthcare Inc.
Company Stats
- Market Cap
- $2.2B
- as of Sep 30, 2026
- Enterprise Value
- $3.1B
- Shares Outstanding
- 47.4M
- Free Float
- 98.5%
Income Statement
- Revenue
- $1.1B
- Operating Income
- $309.4M
- Net Income
- $190.3M
- EBITDA
- $340.7M
- Revenue Growth, 3Y
- -1.2%
- FCF Margin, 3Y Avg
- 21.8%
- FCF Margin, Worst Year
- 21.3%
Cash Flow
- Free Cash Flow
- $246.4M
- FCF Yield
- 11.3%
- Owner FCF Yield
- 10.8%
Balance Sheet
- Cash & Equivalents
- $63.9M
- Total Debt
- $1.0B
- Net Debt
- $936.1M
- Net Debt / EBITDA
- 2.75x
- EV / EBITDA
- 9.13x
- Net Debt / EBIT
- 3.03x
Returns & Capital
- Share Repurchases
- $156.3M
- Buyback Yield, 3Y Avg
- 3.6%
- SBC, 3Y Avg
- $12.0M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2026 | $1.1B | $246.4M | 22.6% |
| FY2025 | $1.1B | $243.3M | 21.4% |
| FY2024 | $1.1B | $239.4M | 21.3% |
| FY2023 | $1.1B | $221.9M | 19.7% |
| FY2022 | $1.1B | $250.3M | 23.0% |
Annual filing data through FY ended March 31, 2026; shares and float as of October 28, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back
Prestige Consumer Healthcare Buys Breathe Right in $1.045 Billion Asset Deal